Breaking News Instant updates and real-time market news.

PTCT

PTC Therapeutics

$38.27

0.29 (0.76%)

16:11
08/07/18
08/07
16:11
08/07/18
16:11

PTC Therapeutics sees FY18 revenue $260M-$295M, consensus $271.82M

PTC anticipates Translarna FY18 net product revenue $170M-$185M. PTC projects a 5-year compound annual growth rate of 15% for net product revenues, representing continued strong growth year-over-year by increasing penetration in current countries and pursuing opportunities for label expansion. PTC anticipates Emflaza net product revenue for the FY18 to be between $90M-$110M. GAAP R&D and SG&A expense for the FY18 is anticipated to be $280M-$290M and non-GAAP R&D and SG&A expense $250M-$260M, excluding estimated non-cash, stock-based compensation expense of approximately $30M.

PTCT PTC Therapeutics
$38.27

0.29 (0.76%)

06/20/18
WBLR
06/20/18
NO CHANGE
WBLR
Outperform
PTC Therapeutics weakness on Sarepta data overblown, says William Blair
William Blair analyst Raju Prasad believes the weakness in shares of PTC Therapeutics (PTCT) following Sarepta's (SRPT) micro-dystrophin gene therapy data is overblown. In a best-case scenario, the micro-dystrophin gene therapy could be approved in late 2021/early 2022 in the United States and potentially 2022/2023 in Europe, Prasad tells investors in a research note. As such, the analyst believes PTC management's projected five-year annual growth of 15% for Translarna due to increasing penetration in existing countries and potential label expansion remains likely. He still views Translarna and Emflaza revenues through 2022 plus cash on hand worth at least $35 per share, with $12 to $20 per share upside coming from risdiplam's potential in spinal muscular atrophy. Prasad keeps an Outperform rating on PTC Therapeutics.
07/19/18
FBCO
07/19/18
INITIATION
Target $49
FBCO
Outperform
PTC Therapeutics initiated with an Outperform at Credit Suisse
Credit Suisse initiated PTC Therapeutics with an Outperform and $49 price target.
07/20/18
WBLR
07/20/18
NO CHANGE
WBLR
Outperform
William Blair positive on PTC's acquisition of Agilis
William Blair analyst Raju Prasad views PTC Therapeutics' acquisition of Agilis Biotherapeutics favorably saying it diversifies the company's pipeline and provides it with a "unique CNS-focused gene therapy platform with several catalysts." Prasad keeps an Outperform rating on PTC Therapeutics.
07/24/18
SBSH
07/24/18
NO CHANGE
Target $50
SBSH
Buy
PTC Therapeutics price target raised to $50 from $35 at Citi
Citi analyst Joel Beatty raised his price target for PTC Therapeutics to $50 and maintains a Buy rating on the name. Continued growth in sales from the company's Duchenne muscular dystrophy franchise, especially Translarna outside the U.S., will contribute to push the stock higher, Beatty tells investors in a research note. The analyst also believes the data so far for RG7916 in type 1 spinal muscular atrophy patients suggests it is an effective drug and that further upside could come later this year. Further, he sees PTC's recent acquisition of gene therapy company Agilis as providing a high level of synergy.

TODAY'S FREE FLY STORIES

FB

Facebook

$132.47

0.85 (0.65%)

18:32
11/20/18
11/20
18:32
11/20/18
18:32
Periodicals
Facebook ads system was down today for some users, Bloomberg says »

Facebook's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

EMCI

EMC Insurance

$32.33

1.1 (3.52%)

18:28
11/20/18
11/20
18:28
11/20/18
18:28
Hot Stocks
EMC Insurance announces receipt of proposal from EMCC to buy all of its shares »

EMC Insurance announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EEX

Emerald Expositions Events

$11.09

0.17 (1.56%)

18:26
11/20/18
11/20
18:26
11/20/18
18:26
Hot Stocks
Emerald Expositions Events announces $20M share repurchase program »

The company anticipates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LIVN

LivaNova

$98.00

-22.28 (-18.52%)

18:26
11/20/18
11/20
18:26
11/20/18
18:26
Recommendations
LivaNova analyst commentary  »

LivaNova price decline on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 27

    Nov

BKH

Black Hills

$64.40

0.92 (1.45%)

18:24
11/20/18
11/20
18:24
11/20/18
18:24
Hot Stocks
Black Hills Energy receives approval to construct $54M gas pipeline in Wyoming »

Black Hills announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,026.00

7 (0.69%)

, GOOGL

Alphabet Class A

$1,031.22

4.99 (0.49%)

18:19
11/20/18
11/20
18:19
11/20/18
18:19
Periodicals
Google expands Moffett Park presence again, SVBJ says »

Google is once again…

GOOG

Alphabet

$1,026.00

7 (0.69%)

GOOGL

Alphabet Class A

$1,031.22

4.99 (0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 03

    Mar

SE

Sea Limited

$12.18

-0.52 (-4.09%)

18:04
11/20/18
11/20
18:04
11/20/18
18:04
Earnings
Sea Limited reports Q3 net loss ($237.6M) vs. ($127.1M) last year »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BILI

Bilibili

$13.61

0.575 (4.41%)

18:03
11/20/18
11/20
18:03
11/20/18
18:03
Earnings
Bilibili reports Q3 revenue $157.1M, consensus $146.72M »

Reports Q3 adjusted net…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

LTM

Latam Airlines

$9.24

-0.4 (-4.15%)

18:01
11/20/18
11/20
18:01
11/20/18
18:01
Hot Stocks
Breaking Hot Stocks news story on Latam Airlines »

LATAM Airlines reports Q3…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

CE

Celanese

$100.26

-1.53 (-1.50%)

18:01
11/20/18
11/20
18:01
11/20/18
18:01
Hot Stocks
Celanese increases Fortron polyphenylene sulphide price by 85c per kg »

The price increases will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$317.77

-3.09 (-0.96%)

, TSLA

Tesla

$347.60

-5.88 (-1.66%)

17:55
11/20/18
11/20
17:55
11/20/18
17:55
Periodicals
NASA to investigate workplace culture at Boeing, SpaceX, Reuters says »

NASA said that it plans…

BA

Boeing

$317.77

-3.09 (-0.96%)

TSLA

Tesla

$347.60

-5.88 (-1.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 13

    Dec

PLWTY

Panalpina World Transport

$0.00

(0.00%)

17:52
11/20/18
11/20
17:52
11/20/18
17:52
Upgrade
Panalpina World Transport rating change  »

Panalpina World Transport…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VLKAY

Volkswagen

$0.00

(0.00%)

, DDAIF

Daimler AG

$0.00

(0.00%)

17:52
11/20/18
11/20
17:52
11/20/18
17:52
Hot Stocks
British Columbia sets path for 100% zero-emission vehicle sales by 2040 »

In a move aimed at…

VLKAY

Volkswagen

$0.00

(0.00%)

DDAIF

Daimler AG

$0.00

(0.00%)

NSANY

Nissan

$0.00

(0.00%)

TM

Toyota

$117.29

0.2 (0.17%)

F

Ford

$9.06

-0.19 (-2.05%)

HMC

Honda

$27.60

-0.46 (-1.64%)

GM

General Motors

$35.09

-0.58 (-1.63%)

FCAU

Fiat Chrysler

$15.83

-0.585 (-3.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 23

    Jan

  • 25

    Apr

  • 24

    Jul

  • 23

    Oct

SPY

SPDR S&P 500 ETF Trust

$264.12

-5.16 (-1.92%)

, SPX

S&P 500

$0.00

(0.00%)

17:45
11/20/18
11/20
17:45
11/20/18
17:45
General news
U.S says China has not changed its 'unfair' trade practices »

The Office of the United…

SPY

SPDR S&P 500 ETF Trust

$264.12

-5.16 (-1.92%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RBA

Ritchie Bros.

$34.27

-0.24 (-0.70%)

17:42
11/20/18
11/20
17:42
11/20/18
17:42
Recommendations
Ritchie Bros. analyst commentary  »

Ritchie Bros exhibiting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FL

Foot Locker

$46.10

-2.69 (-5.51%)

17:39
11/20/18
11/20
17:39
11/20/18
17:39
Earnings
Breaking Earnings news story on Foot Locker »

Foot Locker sees Q4 EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

FE

FirstEnergy

$37.96

-0.58 (-1.50%)

17:39
11/20/18
11/20
17:39
11/20/18
17:39
Periodicals
FirstEnergy in pact to sell West Lorain facility to Starwood Energy, WSJ says »

FirstEnergy Generation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FIZZ

National Beverage

$90.53

-3.14 (-3.35%)

17:39
11/20/18
11/20
17:39
11/20/18
17:39
Hot Stocks
National Beverage announces special cash dividend of $2.90 per share »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OSK

Oshkosh

$65.31

-0.81 (-1.23%)

17:30
11/20/18
11/20
17:30
11/20/18
17:30
Syndicate
Breaking Syndicate news story on Oshkosh »

Oshkosh files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 04

    Dec

  • 05

    Dec

MDU

MDU Resources

$26.10

-0.49 (-1.84%)

17:27
11/20/18
11/20
17:27
11/20/18
17:27
Hot Stocks
MDU Resources sees 2019-2023 CapEx $2.6B »

"We have identified…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDU

MDU Resources

$26.10

-0.49 (-1.84%)

17:26
11/20/18
11/20
17:26
11/20/18
17:26
Earnings
MDU Resources narrows FY18 EPS view to $1.30-$1.45 from $1.25-$1.45 

FY18 consensus $1.39.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FL

Foot Locker

$46.10

-2.69 (-5.51%)

17:22
11/20/18
11/20
17:22
11/20/18
17:22
Earnings
Foot Locker backs FY18 EPS growth view in double digits, consensus $4.48 »

Backs FY18 SSS growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

FL

Foot Locker

$46.10

-2.69 (-5.51%)

17:19
11/20/18
11/20
17:19
11/20/18
17:19
Hot Stocks
Breaking Hot Stocks news story on Foot Locker »

Foot Locker sees Q4 SSS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

FL

Foot Locker

$46.10

-2.69 (-5.51%)

17:17
11/20/18
11/20
17:17
11/20/18
17:17
Hot Stocks
Foot Locker says women's business was the strongest in footwear »

Says pleased by Foot…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

CPRT

Copart

$47.30

-1.255 (-2.58%)

17:16
11/20/18
11/20
17:16
11/20/18
17:16
Earnings
Copart reports Q1 fully diluted EPS 47c, consensus 47c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.